Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2021

Month: February

Request Number: A-2019-000873

Request Summary: Letter from Therapeutic Products Directorate to Ranbaxy certifying that the examination of RAN-Sildenafil (25, 50, 100 mg) was complete, approved and a Notice of Compliance would not be issued until the requirements of the Patented Medicines (NOC) Regs were met. Subm # (139955). HC # (9427-r0857\2-53). Letters issued prior to Nov. 8, 2012.

Disposition: Disclosed in part

Number of pages: 2

Date modified: